Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Yi Xue

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Biomaterials|January 18, 2011
Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitizationHui Yi Xue, Ho Lun Wong
ACS Nano|August 16, 2011
Solid lipid-PEI hybrid nanocarrier: an integrated approach to provide extended, targeted, and safer siRNA therapy of prostate cancer in an all-in-one mannerHui-Yi Xue, Ho-Lun Wong
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 29, 2012
Targeting megalin to enhance delivery of anti-clusterin small-interfering RNA nanomedicine to chemo-treated breast cancerHui Yi Xue, Ho Lun Wong
Current Drug Delivery|March 2, 2018
Therapeutic Nanotechnology for Bone Infection Treatment - State of the ArtPengbo Guo, Hui-Yi Xue, Ho-Lun Wong
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 30, 2016
A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapyHui Yi Xue, Ngoc Tran, Ho Lun Wong
International Journal of Pharmaceutics|August 2, 2012
A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA)Mayuri Narvekar, Hui Yi Xue, Ho Lun Wong
Nanomedicine (London, England)|February 21, 2014
Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicineHui Yi Xue, Shimeng Liu, Ho Lun Wong
International Journal of Pharmaceutics|August 19, 2022
Development of local injectable, bone-targeting nanocarriers of triptolide for treatment of bone-only metastasisWucheng Wen, Pengbo Guo, Hui Yi Xue, et al.
International Journal of Nanomedicine|September 2, 2017
Nanomedicine applications in the treatment of breast cancer: current state of the artDi Wu, Mengjie Si, Hui-Yi Xue, et al.
Current Pharmaceutical Design|June 2, 2015
Lipid-Based Nanocarriers for RNA DeliveryHui Yi Xue, Pengbo Guo, Wu-Cheng Wen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Biomaterials|January 18, 2011
Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitizationHui Yi Xue, Ho Lun Wong
ACS Nano|August 16, 2011
Solid lipid-PEI hybrid nanocarrier: an integrated approach to provide extended, targeted, and safer siRNA therapy of prostate cancer in an all-in-one mannerHui-Yi Xue, Ho-Lun Wong
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 29, 2012
Targeting megalin to enhance delivery of anti-clusterin small-interfering RNA nanomedicine to chemo-treated breast cancerHui Yi Xue, Ho Lun Wong
Current Drug Delivery|March 2, 2018
Therapeutic Nanotechnology for Bone Infection Treatment - State of the ArtPengbo Guo, Hui-Yi Xue, Ho-Lun Wong
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 30, 2016
A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapyHui Yi Xue, Ngoc Tran, Ho Lun Wong
International Journal of Pharmaceutics|August 2, 2012
A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA)Mayuri Narvekar, Hui Yi Xue, Ho Lun Wong
Nanomedicine (London, England)|February 21, 2014
Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicineHui Yi Xue, Shimeng Liu, Ho Lun Wong
International Journal of Pharmaceutics|August 19, 2022
Development of local injectable, bone-targeting nanocarriers of triptolide for treatment of bone-only metastasisWucheng Wen, Pengbo Guo, Hui Yi Xue, et al.
International Journal of Nanomedicine|September 2, 2017
Nanomedicine applications in the treatment of breast cancer: current state of the artDi Wu, Mengjie Si, Hui-Yi Xue, et al.
Current Pharmaceutical Design|June 2, 2015
Lipid-Based Nanocarriers for RNA DeliveryHui Yi Xue, Pengbo Guo, Wu-Cheng Wen, et al.
Pageof 3